PD-L1 expression is considered to play a role in the protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, which promotes the glucose metabolism of the tumor through the synthesis of glycolytic enzymes [21]. Here, MTOR is linked to neoplasm.